
IRVINE, Calif., May 7, 2025 – PRISM MediaWire – Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live Zoom webinar to discuss the company’s financial results at 2:00 p.m. PT that same day.
Registration for the live webinar, which will discuss financial results and include Q&A, is required at the following link: Oncocyte Q1 2025 Earnings Webinar.
An archived replay will be available after the call concludes on Oncocyte’s investor relations website at https://investors.oncocyte.com.
About Oncocyte:
Oncocyte is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.oncocyte.com/ for more information.
Investor Contact:
Doug Farrell
LifeSci Advisors LLC
Source: Oncocyte